FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, namely to obtaining cell lines used for development of treating with target preparations, and can be used in medicine. Cell line crov Cel of human mucinous ovarian carcinoma is characterized by presence in exon 9 of gene PIK3CA of somatic missense mutation E542K (1624 G/A), leading to amino acid replacement in 542 codon (p.Glu542Lys). Mutation is registered in international database (COSMIC, COSM760Id) and is associated with higher sensitivity to mTOR inhibitor therapy. Obtained cell line is stored in Russian national collection of industrial microorganisms FGUPGosNIIGenetika under No. 160.
EFFECT: invention enables to obtain cell line crov Cel of human mucinous ovarian carcinoma, which has stable culture and morphological characteristics.
1 cl, 8 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SUBDERMAL XENOGRAFTS OF CELL LINE OF AMELANOTIC HUMAN SKIN MELANOMA MEL RAC WITH MUTATION NRAS FOR PRECLINICAL STUDY OF ANTINEOPLASTIC TARGETED AGENTS | 2016 |
|
RU2651939C2 |
| METHOD FOR EARLY DIAGNOSIS OF NEOPLASTIC TRANSFORMATION OF ENDOMETRIOID OVARIAN CYSTS | 2020 |
|
RU2730952C1 |
| METHOD OF PRODUCTION OF SUBDERMAL XENOGRAFTS OF CELL LINE OF PEOPLE SKIN MELANOMA mel Cher WITH MUTATION V600E BRAF FOR PRECLINICAL STUDY OF ANTINEOPLASTIC TARGETED AGENTS | 2014 |
|
RU2572569C1 |
| BIOMARKERS | 2005 |
|
RU2429297C2 |
| METHOD FOR MODELING OVARIAN CANCER EXPERIMENTALLY IN RATS | 2020 |
|
RU2743219C1 |
| BIOMARKER | 2005 |
|
RU2385944C2 |
| METHOD FOR PREDICTION OF RISK OF PROGRESSION OF METASTATIC COLORECTAL CANCER AFTER ANTI-EGFR THERAPY | 2024 |
|
RU2820402C1 |
| BIOMEDICAL CELL PRODUCT WITH SPECIFIC ANTITUMOR ACTIVITY, REPRESENTED BY POPULATIONS OF LYMPHOKINE-ACTIVATED KILLERS AND ANTI-HER2 CAR-γδΤ-OIL AND ANTI-HER2 CAR-T-NK | 2022 |
|
RU2786210C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF TYPE OF STOMACH CANCER BY IMMUNOHISTOCHEMICAL TESTING METHOD | 2023 |
|
RU2813670C1 |
| BIOMEDICAL CELL PRODUCT WITH ANTI-HER2 SPECIFIC ANTI-TUMOUR ACTIVITY | 2019 |
|
RU2728361C1 |
